PA
TNGX icon

Profund Advisors’s Tango Therapeutics TNGX Stock Holding History

Profund Advisors’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$999K Sell
47,735
-36,024
-43% -$501K 0.04% 348
2025
Q4 		$742K Buy
83,759
+52,471
+168% +$452K 0.02% 432
2025
Q3 		$263K Buy
+31,288
New +$212K 0.01% 816
2024
Q4 		– Sell
-20,473
Closed -$158K – 1186
2024
Q3 		$158K Buy
20,473
+6,580
+47% +$62.8K 0.01% 1078
2024
Q2 		$119K Sell
13,893
-20,404
-59% -$158K ﹤0.01% 1036
2024
Q1 		$272K Buy
+34,297
New +$368K 0.01% 906

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Profund Advisors's TNGX Position: Q1 2026 in Review

Profund Advisors reduced its Tango Therapeutics (TNGX) stake by 43% in Q1 2026, selling an estimated $501K and leaving 47,735 shares worth $999K. The position accounts for 0.04% of the portfolio, ranked #348.

Profund Advisors first reported a position in TNGX in Q1 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Profund Advisors held 47,735 shares of Tango Therapeutics worth $999K as of Q1 2026.
  • Profund Advisors sold 36,024 Tango Therapeutics shares in Q1 2026, an estimated $501K.
  • Tango Therapeutics made up 0.04% of Profund Advisors's portfolio in Q1 2026, its #348 holding.
  • Profund Advisors first reported a position in Tango Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.